The U.S. Court of Appeals for the Second Circuit ruled Monday that a lower court lacked jurisdiction over Pfizer Inc.’s challenge to more than $8 million in interest it was denied for overpaying the Internal Revenue Service on its 2008 tax returns, saying the lawsuit could only be brought in U.S. Federal Claims Court.

The decision from a three-judge panel of the appeals court exposed a circuit split on whether a dispute for “overpayment interest” qualifies as the type of action that gives federal district courts concurrent jurisdiction over such suits involving the IRS.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]